Annual FCF
-$15.50 M
+$4.55 M+22.71%
December 31, 2023
Summary
- As of February 7, 2025, MTNB annual free cash flow is -$15.50 million, with the most recent change of +$4.55 million (+22.71%) on December 31, 2023.
- During the last 3 years, MTNB annual FCF has risen by +$1.88 million (+10.81%).
- MTNB annual FCF is now -402.79% below its all-time high of -$3.08 million, reached on December 31, 2013.
Performance
MTNB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.50 M
-$394.00 K-12.69%
September 30, 2024
Summary
- As of February 7, 2025, MTNB quarterly free cash flow is -$3.50 million, with the most recent change of -$394.00 thousand (-12.69%) on September 30, 2024.
- Over the past year, MTNB quarterly FCF has increased by +$935.00 thousand (+21.08%).
- MTNB quarterly FCF is now -2231.78% below its all-time high of -$150.10 thousand, reached on March 31, 2013.
Performance
MTNB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$16.95 M
+$935.00 K+5.23%
September 30, 2024
Summary
- As of February 7, 2025, MTNB TTM free cash flow is -$16.95 million, with the most recent change of +$935.00 thousand (+5.23%) on September 30, 2024.
- Over the past year, MTNB TTM FCF has dropped by -$1.70 million (-11.12%).
- MTNB TTM FCF is now -11195.14% below its all-time high of -$150.10 thousand, reached on March 31, 2013.
Performance
MTNB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MTNB Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.7% | +21.1% | -11.1% |
| 3 y3 years | +10.8% | +21.1% | -11.1% |
| 5 y5 years | -42.7% | +21.1% | -11.1% |
MTNB Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +22.7% | -46.1% | +39.3% | -11.1% | +17.1% |
| 5 y | 5-year | -6.9% | +22.7% | -304.8% | +41.4% | -16.9% | +17.1% |
| alltime | all time | -402.8% | +22.7% | -2231.8% | +41.4% | <-9999.0% | +17.1% |
Matinas BioPharma Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.50 M(+12.7%) | -$16.95 M(-5.2%) |
| Jun 2024 | - | -$3.11 M(-46.2%) | -$17.89 M(+4.1%) |
| Mar 2024 | - | -$5.77 M(+26.0%) | -$17.18 M(+10.9%) |
| Dec 2023 | -$15.50 M(-22.7%) | -$4.58 M(+3.2%) | -$15.50 M(+1.6%) |
| Sep 2023 | - | -$4.43 M(+85.2%) | -$15.26 M(-4.9%) |
| Jun 2023 | - | -$2.40 M(-41.4%) | -$16.04 M(-14.8%) |
| Mar 2023 | - | -$4.09 M(-5.9%) | -$18.83 M(-6.1%) |
| Dec 2022 | -$20.05 M(+29.5%) | -$4.34 M(-16.8%) | -$20.05 M(+1.8%) |
| Sep 2022 | - | -$5.22 M(+0.7%) | -$19.70 M(-3.7%) |
| Jun 2022 | - | -$5.19 M(-2.2%) | -$20.45 M(+26.8%) |
| Mar 2022 | - | -$5.30 M(+32.8%) | -$16.13 M(+4.2%) |
| Dec 2021 | -$15.48 M(-10.9%) | -$3.99 M(-33.2%) | -$15.48 M(-2.0%) |
| Sep 2021 | - | -$5.97 M(+590.9%) | -$15.80 M(+5.0%) |
| Jun 2021 | - | -$864.70 K(-81.4%) | -$15.05 M(-13.3%) |
| Mar 2021 | - | -$4.65 M(+8.0%) | -$17.35 M(-0.1%) |
| Dec 2020 | -$17.37 M(+19.8%) | -$4.31 M(-17.6%) | -$17.37 M(-3.3%) |
| Sep 2020 | - | -$5.23 M(+64.9%) | -$17.96 M(+6.4%) |
| Jun 2020 | - | -$3.17 M(-32.1%) | -$16.88 M(+4.7%) |
| Mar 2020 | - | -$4.67 M(-4.7%) | -$16.13 M(+11.3%) |
| Dec 2019 | -$14.50 M(+33.5%) | -$4.90 M(+18.1%) | -$14.50 M(+18.7%) |
| Sep 2019 | - | -$4.15 M(+71.7%) | -$12.22 M(+11.2%) |
| Jun 2019 | - | -$2.41 M(-20.5%) | -$10.98 M(-0.0%) |
| Mar 2019 | - | -$3.04 M(+16.0%) | -$10.99 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$10.86 M(-12.5%) | -$2.62 M(-10.1%) | -$10.86 M(+5.7%) |
| Sep 2018 | - | -$2.91 M(+20.5%) | -$10.27 M(+0.9%) |
| Jun 2018 | - | -$2.42 M(-16.9%) | -$10.18 M(-17.1%) |
| Mar 2018 | - | -$2.91 M(+43.0%) | -$12.28 M(-1.0%) |
| Dec 2017 | -$12.40 M(+102.7%) | -$2.03 M(-27.9%) | -$12.40 M(-0.7%) |
| Sep 2017 | - | -$2.82 M(-37.6%) | -$12.48 M(+13.2%) |
| Jun 2017 | - | -$4.52 M(+49.0%) | -$11.03 M(+45.0%) |
| Mar 2017 | - | -$3.03 M(+43.3%) | -$7.61 M(+24.3%) |
| Dec 2016 | -$6.12 M(-22.5%) | -$2.12 M(+54.9%) | -$6.12 M(+19.0%) |
| Sep 2016 | - | -$1.37 M(+24.9%) | -$5.14 M(-13.6%) |
| Jun 2016 | - | -$1.09 M(-29.1%) | -$5.95 M(-16.3%) |
| Mar 2016 | - | -$1.54 M(+35.4%) | -$7.11 M(-9.9%) |
| Dec 2015 | -$7.89 M(-4.4%) | -$1.14 M(-47.6%) | -$7.89 M(-13.9%) |
| Sep 2015 | - | -$2.17 M(-3.5%) | -$9.17 M(+6.2%) |
| Jun 2015 | - | -$2.25 M(-3.3%) | -$8.63 M(+4.1%) |
| Mar 2015 | - | -$2.33 M(-3.7%) | -$8.30 M(+0.6%) |
| Dec 2014 | -$8.25 M(+167.7%) | -$2.42 M(+47.3%) | -$8.25 M(+9.0%) |
| Sep 2014 | - | -$1.64 M(-14.1%) | -$7.57 M(+10.6%) |
| Jun 2014 | - | -$1.91 M(-16.3%) | -$6.84 M(+31.2%) |
| Mar 2014 | - | -$2.28 M(+31.8%) | -$5.21 M(+69.2%) |
| Dec 2013 | -$3.08 M | -$1.73 M(+89.3%) | -$3.08 M(+128.3%) |
| Sep 2013 | - | -$915.20 K(+221.7%) | -$1.35 M(+210.6%) |
| Jun 2013 | - | -$284.50 K(+89.5%) | -$434.60 K(+189.5%) |
| Mar 2013 | - | -$150.10 K | -$150.10 K |
FAQ
- What is Matinas BioPharma Holdings annual free cash flow?
- What is the all time high annual FCF for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual FCF year-on-year change?
- What is Matinas BioPharma Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly FCF year-on-year change?
- What is Matinas BioPharma Holdings TTM free cash flow?
- What is the all time high TTM FCF for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings TTM FCF year-on-year change?
What is Matinas BioPharma Holdings annual free cash flow?
The current annual FCF of MTNB is -$15.50 M
What is the all time high annual FCF for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual free cash flow is -$3.08 M
What is Matinas BioPharma Holdings annual FCF year-on-year change?
Over the past year, MTNB annual free cash flow has changed by +$4.55 M (+22.71%)
What is Matinas BioPharma Holdings quarterly free cash flow?
The current quarterly FCF of MTNB is -$3.50 M
What is the all time high quarterly FCF for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly free cash flow is -$150.10 K
What is Matinas BioPharma Holdings quarterly FCF year-on-year change?
Over the past year, MTNB quarterly free cash flow has changed by +$935.00 K (+21.08%)
What is Matinas BioPharma Holdings TTM free cash flow?
The current TTM FCF of MTNB is -$16.95 M
What is the all time high TTM FCF for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high TTM free cash flow is -$150.10 K
What is Matinas BioPharma Holdings TTM FCF year-on-year change?
Over the past year, MTNB TTM free cash flow has changed by -$1.70 M (-11.12%)